X4 Pharmaceuticals, Inc. Financial Ratios — XFOR Stock

Profitability (USD)

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-268.49	-76.25	-56.77	-53.69	-43.82	-73.9	-68.83	-66.81	-25.5	-36.25
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	- -	100	- -	- -	- -	68.83	83.6
EBITDA Margin (%)	- -	- -	- -	- -	- -	-1,984.1	- -	- -	- -	-5,498.83	-243.8
Operating Margin (%)	- -	- -	- -	- -	- -	-1,995.8	- -	- -	- -	-5,529.96	-247.44
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	515.83	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	-2,066.1	- -	- -	- -	-1,452.48	-225.44
Profit Margin (%)	- -	- -	- -	- -	- -	-2,071.03	- -	- -	- -	-1,464.61	-225.55
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	-2,071.03	- -	- -	- -	-1,464.61	-225.55
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	0.14	- -	0.13	8.27	1.11	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	7	15	12	8	23	38	40	38	58	78	77
ST Debt	2	5	2	- -	1	1	2	3	1	1	1
LT Debt	5	10	10	8	22	38	38	36	57	77	76
Total Debt/EBITDA	-0.59	-0.71	-0.38	-0.27	-0.48	-0.65	-0.53	-0.44	-0.54	-0.56	-0.9
Net Debt/EBITDA	-0.04	-0.57	2.01	0.79	2.22	0.76	0.64	1.01	0.42	-0.14	1.64
Total Debt/EBIT	-0.57	-0.7	-0.38	-0.27	-0.48	-0.64	-0.53	-0.44	-0.54	-0.55	-0.89
Net Debt/EBIT	-0.03	-0.56	2	0.79	2.22	0.76	0.64	1	0.42	-0.14	1.62
EBITDA to Interest Expense	-26.02	-8.62	-15.43	-40.25	-22.22	-22.14	-20.55	-21.93	-18.54	-16.04	-9.64
EBITDA-CapEx/Interest Expense	-26.38	-8.65	-15.45	-40.25	-22.3	-22.65	-20.72	-21.96	-18.55	-16.87	-9.98
EBIT to Interest Expense	-26.84	-8.73	-15.52	-40.4	-22.27	-22.27	-20.69	-22.06	-18.61	-16.13	-9.79
Interest Expense	- -	3	2	1	2	3	4	4	6	9	9
Common Equity/Total Assets	-372.37	-767.85	-113.53	-375.71	-82.16	-158.02	-241.38	-242.06	-324.42	-351.9	-204.66
Long-Term Debt/Equity (%)	- -	- -	16.9	36.55	17.04	51.73	58.86	48.49	111.9	346.9	40.95
Long-Term Debt/Capital (%)	-16.67	-23.5	-12.4	-6.2	-20.18	-24.19	-15.6	-10.62	-13.63	-17.57	-14.75
Long-Term Debt/Total Assets (%)	49.46	133.18	12.21	21.93	13.7	30.65	32.36	23.08	38.83	52.47	26.27
Total Debt/Equity (%)	-20.96	-27.03	20.84	36.55	17.73	52.81	61.77	51.88	114.06	352.55	41.49
Total Debt/Capital (%)	-25.49	-35.47	-15.29	-6.2	-21	-24.69	-16.37	-11.36	-13.89	-17.86	-14.94
Total Debt/Total Assets (%)	75.65	201.07	15.06	21.93	14.26	31.29	33.95	24.69	39.58	53.32	26.61
Net Debt to Equity	-1.27	-21.66	-109.96	-105.83	-82.1	-62.54	-74.29	-118.97	-87.37	89.06	-75.56
Net Debt/Capital (%)	-1.24	-26.56	41.17	14.46	45.09	19.42	14.73	19.16	8.61	-4	19.17
EBITDA	-12	-22	-32	-29	-48	-60	-75	-88	-107	-141	-86
EBITDA-CapEx	-12	-22	-32	-29	-48	-61	-75	-88	-107	-148	-89
Operating Income (Loss)	-13	-22	-32	-29	-48	-60	-75	-88	-108	-141	-87

Liquidity (USD)

API Chat

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	1.01	0.25	7.19	5.7	13.36	6.59	5.83	5.45	5	3.1	9.82
Current Ratio	1.26	0.47	7.45	6.5	13.68	6.97	6.27	5.76	5.34	3.41	10.16
Quick Ratio	1.24	0.36	7.34	6.23	13.57	6.66	5.89	5.5	5.02	3.16	9.84
CFO/Avg Current Liab	- -	-2.31	-2.45	-3.16	-6.47	-5.5	-5.46	-4.24	-4.27	-4.7	-2.92
Common Equity/Total Assets	-372.37	-767.85	-113.53	-375.71	-82.16	-158.02	-241.38	-242.06	-324.42	-351.9	-204.66
Long-Term Debt/Equity (%)	- -	- -	16.9	36.55	17.04	51.73	58.86	48.49	111.9	346.9	40.95
Long-Term Debt/Capital (%)	-16.67	-23.5	-12.4	-6.2	-20.18	-24.19	-15.6	-10.62	-13.63	-17.57	-14.75
Long-Term Debt/Total Assets (%)	49.46	133.18	12.21	21.93	13.7	30.65	32.36	23.08	38.83	52.47	26.27
Total Debt/Equity (%)	-20.96	-27.03	20.84	36.55	17.73	52.81	61.77	51.88	114.06	352.55	41.49
Total Debt/Capital (%)	-25.49	-35.47	-15.29	-6.2	-21	-24.69	-16.37	-11.36	-13.89	-17.86	-14.94
Total Debt/Total Assets (%)	75.65	201.07	15.06	21.93	14.26	31.29	33.95	24.69	39.58	53.32	26.61
CFO/Total Liabilities	-24.68	-33.72	-123.61	-176.48	-152.66	-117.47	-134.38	-94.56	-100.37	-105.31	-82.19
CFO/CapEx	-63.62	-296.42	-663.6	- -	-276.18	-43.19	-115.29	-748.56	-1,608.53	-17.87	-28.54
Altman's Z-Score	-9.39	-21.28	-1.18	-6.67	0.86	-2.43	-4.9	-4.53	-6.03	-8.44	-2.06

Working Capital (USD)

API Chat

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	4.78	42.74
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	76.37	8.54
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.57	1.58
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	645.05	231.29
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.41	1.04
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	887.15	352.18
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	-165.73	-112.36
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	-568.68	-222.75
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	3	4
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	1
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	3
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	26	6	123	129	59	63	149	148	169
- Cash & Cash Equivalents	7	3	77	31	126	79	82	122	99	56	217
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	7	15	12	8	23	38	40	38	58	78	77
Enterprise Value	- -	12	-38	-16	20	89	17	-20	93	124	-7
Total Capital	-28	-43	-80	-127	-109	-156	-243	-338	-419	-437	-517
Total Debt/Capital (%)	-25.49	-35.47	-15.29	-6.2	-21	-24.69	-16.37	-11.36	-13.89	-17.86	-14.94
Total Debt / EV	16.54	1.25	-0.32	-0.48	1.14	0.43	2.35	-1.9	0.63	0.63	-11.81
EV/Sales	- -	- -	- -	- -	- -	29.61	- -	- -	- -	48.31	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	26	6	123	129	59	63	149	148	169
Diluted Enterprise Value	- -	12	-38	-16	20	89	17	-20	108	170	29
EV per Share	14.06	396.15	- -	- -	52.3	132.74	19.76	- -	15.72	18.43	- -
TTM Sales	- -	- -	- -	- -	- -	3	- -	- -	- -	3	35
TTM EBITDA	-12	-22	-32	-29	-48	-60	-75	-88	-107	-141	-86
TTM Operating Income	-13	-22	-32	-29	-48	-60	-75	-88	-108	-141	-87
TTM Cash Flow to Firm	-10	-19	-26	-25	-46	-56	-67	-73	-91	-122	-77
TTM Free Cash Flow to Firm	-10	-19	-26	-25	-46	-55	-67	-73	-91	-115	-74

Multiples (USD)

API Chat

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	-0.95	-0.25	-2.58	-2.25	-0.84	-0.82	-1.55	-1.19	-2.05
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	12	-38	-16	20	89	17	-20	93	124	-7
Low Price	- -	- -	1,872	207	280.8	161.4	54	19.5	17.17	7.84	1.35
EV/Sales	- -	- -	- -	- -	- -	29.61	- -	- -	- -	48.31	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-0.85	-0.74	-3.25	-2.67	-1.94	-1	-2.18	-4.34	-3.16
Price/Earnings High	- -	- -	-1.2	-2.18	-5.17	-3.61	-3.11	-1.78	-4.53	-8.59	-13.05
Price/Earnings Low	- -	- -	-0.63	-0.09	-2.02	-1.74	-0.52	-0.44	-1.01	-1.4	-0.72
Price/Book Value	- -	- -	-0.29	-0.05	-0.93	-0.66	-0.21	-0.17	-0.31	-0.29	-0.28
Price/Book Value Average	- -	- -	-0.31	-0.2	-1.32	-0.85	-0.61	-0.25	-0.46	-0.32	-0.42
Price/Book Value High	- -	- -	-0.44	-0.58	-2.09	-1.15	-0.97	-0.44	-0.96	-0.62	-1.74
Price/Book Value Low	- -	- -	-0.23	-0.02	-0.82	-0.56	-0.16	-0.11	-0.21	-0.1	-0.1
Price/Tangible Book Value	- -	- -	0.45	0.3	1.21	2.83	1.25	1.11	4.42	-28.36	1.06
Price/Tangible Book Value Average	- -	- -	0.49	1.24	1.7	3.63	3.65	1.65	6.52	-31.25	1.57
Price/Tangible Book Value High	- -	- -	0.69	3.66	2.7	4.9	5.85	2.95	13.59	-61.84	6.47
Price/Tangible Book Value Low	- -	- -	0.37	0.15	1.06	2.36	0.98	0.73	3.02	-10.1	0.36
Price/Sales	- -	- -	- -	- -	- -	43.03	- -	- -	- -	57.69	4.82
Price/Sales Average	- -	- -	- -	- -	- -	55.33	- -	- -	- -	63.58	7.12
Price/Sales High	- -	- -	- -	- -	- -	74.69	- -	- -	- -	125.81	29.44
Price/Sales Low	- -	- -	- -	- -	- -	36	- -	- -	- -	20.55	1.63
Price/Cash Flow	- -	- -	-0.94	-0.25	-2.57	-2.19	-0.83	-0.82	-1.55	-1.13	-1.98
Price/Cash Flow Average	- -	- -	-1.04	-1.05	-3.62	-2.82	-2.43	-1.22	-2.28	-1.24	-2.92
Price/Cash Flow High	- -	- -	-1.46	-3.11	-5.74	-3.81	-3.89	-2.17	-4.75	-2.46	-12.07
Price/Cash Flow Low	- -	- -	-0.77	-0.12	-2.25	-1.84	-0.65	-0.54	-1.05	-0.4	-0.67
Price/Free Cash Flow Average	- -	- -	-1.04	-1.05	-3.63	-2.89	-2.45	-1.22	-2.28	-1.32	-3.03
Price/Free Cash Flow High	- -	- -	-1.46	-3.11	-5.76	-3.9	-3.92	-2.17	-4.76	-2.6	-12.51
Price/Free Cash Flow Low	- -	- -	-0.77	-0.12	-2.25	-1.88	-0.66	-0.54	-1.06	-0.43	-0.69
EV/Sales Average	- -	- -	- -	- -	- -	41.91	- -	- -	- -	72.34	3.14
EV/Sales High	- -	- -	- -	- -	- -	61.27	- -	- -	- -	134.57	25.46
EV/Sales Low	- -	- -	- -	- -	- -	22.58	- -	- -	- -	29.3	- -
EV/EBITDA Average	-0.04	-0.57	1.11	-0.13	-1.48	-2.11	-1.74	-0.12	-1.67	-1.32	-1.29
EV/EBITDA High	-0.04	-0.57	0.74	-1.94	-3.62	-3.09	-3.12	-0.96	-3.9	-2.45	-10.44
EV/EBITDA Low	-0.04	-0.57	1.34	0.68	-0.1	-1.14	-0.06	0.48	-0.57	-0.53	0.97
EV/EBIT Average	-0.03	-0.56	1.1	-0.13	-1.48	-2.1	-1.73	-0.12	-1.67	-1.31	-1.27
EV/EBIT High	-0.03	-0.56	0.74	-1.93	-3.61	-3.07	-3.1	-0.95	-3.89	-2.43	-10.29
EV/EBIT Low	-0.03	-0.56	1.34	0.68	-0.1	-1.13	-0.06	0.48	-0.57	-0.53	0.95
Last Price	- -	- -	2,296.8	417.6	321	192.9	68.7	29.79	25.16	22.01	4
High Price	- -	- -	3,550.8	5,164.8	717.9	334.8	321	78.9	77.4	48	24.44
Enterprise Value Average	- -	12	-36	4	71	126	130	10	179	185	110
Enterprise Value High	- -	12	-24	56	173	184	234	84	418	344	894
Enterprise Value Low	- -	12	-43	-20	5	68	4	-42	61	75	-83

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	- -	- -	- -	- -	1	1	1	4	6	6	91
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	1	1	2	6	7	42
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	1	1	2	6	7	42
Revenue per Share	- -	- -	- -	- -	- -	4.48	- -	- -	- -	0.38	0.83
EBITDA per Share	-397.02	-700.58	-2,799.9	-1,894.37	-124.11	-88.94	-87.21	-41.35	-18.07	-20.98	-2.02
Operating Income per Share	-409.59	-709.79	-2,816.92	-1,901.1	-124.38	-89.47	-87.79	-41.59	-18.14	-21.1	-2.05
Basic EPS, GAAP	-427.92	-742.73	-2,961.5	-2,371.72	-138.94	-92.84	-103.34	-44.33	-17.07	-5.59	-1.87
Basic EPS from Cont Ops	-427.31	-742.73	-2,957.66	-2,175.63	-137.4	-92.84	-103.34	-44.33	-17.07	-5.59	-1.87
Diluted EPS, GAAP	-427.92	-742.73	-2,961.5	-2,371.72	-138.94	-92.84	-103.34	-44.33	-17.07	-5.59	-1.87
Diluted EPS from Cont Ops	-427.31	-742.73	-2,957.66	-2,175.63	-137.4	-92.84	-103.34	-44.33	-17.07	-5.59	-1.87
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-349.66	-699.54	-2,433.3	-1,661.55	-125.03	-87.89	-82.61	-36.41	-16.28	-19.53	-2.02
Free Cash Flow per Basic Share	-355.15	-701.9	-2,436.97	-1,661.55	-125.49	-89.92	-83.33	-36.46	-16.29	-20.62	-2.1
Cash & Equivalents per Share	218.5	98.12	6,704.47	2,010.2	328.32	117.61	95.29	57.48	19.27	15.23	5.98
Book Value per Share	-1,144.8	-1,887.53	-8,053.95	-8,841.82	-343.53	-290.12	-329.54	-177.86	-80.6	-76.89	-14.06
Tangible Book Value per Share	-1,109.56	-1,828.53	5,125.46	1,411.86	265.68	68.27	54.83	26.78	5.69	-0.78	3.78

X4 Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)